A meta-analysis showed that TLR9 polymorphisms are associated with increased risk for cancer and some hematological neoplasms, such as non-Hodgkin’s lymphoma and acute myeloid leukemia (AML)37–39. The gene discussed is TLR9; the disease is acute myeloid leukemia.